New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
07:59 EDTVCYTVeracyte weakness a buying opportunity, says Cowen
Cowen feels the recent weakness in Veracyte has created a buying opportunity despite the company's lower than expected Q2 revenues and reduced guidance. The firm calls the stock on of its top small-cap picks, citing underlying GEC growth, a strong pipeline, and low valuation. Cowen maintains its Outperform rating and $22 price target on Veracyte.
News For VCYT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 14, 2014
10:00 EDTVCYTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:02 EDTVCYTVeracyte downgraded to Neutral from Buy at Janney Capital
November 13, 2014
16:12 EDTVCYTVeracyte sees FY14 revenue $38M, consensus $38.48M
Subscribe for More Information
16:11 EDTVCYTVeracyte reports Q3 EPS (37c), consensus (35c)
Subscribe for More Information
November 10, 2014
10:04 EDTVCYTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:17 EDTVCYTVeracyte initiated with an Equal Weight at Morgan Stanley
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use